Trial to assess the safety and antitumor activity of GEN1057 on malignant solid tumors
GCT1057-01
Phase 1 other active
Quick answer
Trial to assess the safety and antitumor activity of GEN1057 on malignant solid tumors for Metastatic or advanced malignant solid tumors is a Phase 1 program (other) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Metastatic or advanced malignant solid tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active